Development Deal, PTV News: Mar 04, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Development Deal, PTV News: Mar 04, 2010
Released on: March 04, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Company
Bristol-Myers Squibb and Allergan in US$ 400M pain drug pact
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Allergan
Allergan, Inc. (NYSE: AGN), headquartered in Irvine, California, is a technology-driven, global health care company providing eye care and speciality pharmaceutical products worldwide. Allergan develops and commercialises products in the eye care pharmaceutical, movement disorder and skin care markets that deliver value to its customers, satisfy unmet medical needs and improve patients' lives.
Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. It is also the parent company of Mead Johnson Nutrition, which manufactures nutritional products such as Enfamil baby formulas and infant vitamin supplements like Tri-Vi-Sol. Bristol-Myers Squibb has a mission to "Extend and Enhance Human Life" and works to discover and develop medicines in areas of serious unmet medical need.